Tuberculous meningitis (TBM) results from the haematogenous dissemination of Mycobacterium tuberculosis from the lung to the brain. Dissemination is believed to occur early during infection, before the development of adaptive immunity. Toll-like receptor 2 (TLR2) mediates recognition of M. tuberculosis and initiates the innate immune response to infection. We hypothesized that polymorphisms in the TLR2 gene influence bacterial dissemination and the development of TBM. A casecontrol study was designed to test the hypothesis. Cases of bacteriologically confirmed pulmonary tuberculosis (TB) (n ¼ 183) and TBM (n ¼ 175), and cord blood controls (n ¼ 389) were enrolled in Vietnam. TLR2 genotype 597CC was associated with susceptibility to TB (odds ratio (OR) ¼ 2.22, 95% confidence interval (CI): 1.23À3.99). The association was found with meningeal rather than pulmonary TB (TBM vs control, OR ¼ 3.26, 95% CI: 1.72À6.18), and was strongest when miliary TB was found on chest radiography (controls vs TBM with miliary TB, OR ¼ 5.28, 95% CI: 2.20À12.65). Furthermore, the association increased with the severity of neurologic symptoms (grade I TBM, OR ¼ 1.93, 95% CI: 0.54À6.92; grade II, OR ¼ 3.32, 95% CI: 0.84À13.2; and grade III, OR ¼ 5.70, 95% CI: 1.81À18.0). These results demonstrate a strong association of TLR2 SNP T597C with the development of TBM and miliary TB and indicate that TLR2 influences the dissemination of M. tuberculosis.
Introduction
Tuberculous meningitis (TBM) is the most severe form of tuberculosis (TB) killing 20À25% of those affected and leaving neurological sequelae in many of those who survive. 1, 2 TBM is caused by the dissemination of Mycobacterium tuberculosis from the lung to the meninges and parenchyma of the brain or spinal cord and forms around 1% of all cases of TB. 3 The reason why some patients develop TBM, but most do not, has not yet been established. There may be host genetic, environmental or bacterial factors that make patients more susceptible to this form of the disease. 4 Many studies suggest that host genetics strongly influences susceptibility to TB. There are data from studies of twins, children with severe primary immunodeficiency due to single gene mutations (for example, IL-12-IFNg pathway), genome-wide scans for susceptibility loci and candidate gene approaches. 5À8 Furthermore, recent immunological and genetic studies support the idea that innate immunity is important in the control of M. tuberculosis. 9 In patients with extra-pulmonary TB, a failure of some of the immune response genes involved in controlling M. tuberculosis may partially explain the dissemination of M. tuberculosis from the lung to other tissues such as the brain. 10 A number of reports have recently found mutations and polymorphisms in Toll-like receptor (TLR) genes that affect host susceptibility to infectious diseases. 11À14 The TLR family contains 10 human proteins (TLR1-10). TLRs are conserved mediators of innate immunity and are essential for microbial antigen recognition by dendritic cells and macrophages. The TLR family are transmembrane proteins with an extracellular domain that recognizes bacterial ligands and an intracellular domain that initiates a signal-transduction cascade, which leads to the expression of cytokines, adhesion molecules and chemokines. 15, 16 TLR2 recognizes lipopeptides, which are ubiquitous in pathogens, including mycobacteria. Lipoarabinomannan of mycobacteria and the 19-kDa M. tuberculosis lipoprotein are both recognized by TLR2. 17, 18 Studies of M. tuberculosis infection in TLR2 knockout mice suggest that TLR2 is important for defence against mycobacterial infection.
19À21 Other studies investigating polymorphic variants of human TLR2 have been performed in patients with bacterial and mycobacterial diseases such as leprosy and TB. One missense mutation, Arg753Gln, was associated with susceptibility to TB and Lyme disease. 22, 23 A TLR2 microsatellite polymorphism was also associated with pulmonary TB in Korea. 24 Previous studies in our cohort suggest that the Tollinterleukin 1 receptor domain containing adaptor protein (TIRAP), an adaptor that mediates signals from TLRs activated by mycobacteria, is associated with susceptibility to TB. The C558T polymorphism of TIRAP was strongly associated with susceptibility to TBM, but not pulmonary TB. 25 A recent study has found that TIRAP S180L polymorphism was associated with infectious diseases including TB in Africa and the heterozygous carriage of this variant was protective against TB. 26 Owing to the central role of TLR2 in the recognition of TB, we hypothesized that TLR2 polymorphisms were associated with susceptibility to disseminated disease, in particular TBM.
Results

TLR2 polymorphisms in TBM patients
To examine whether TLR2 polymorphisms were associated with TBM, we resequenced the TLR2 coding region to identify single nucleotide polymorphisms (SNPs) in 50 TBM patients who were selected from 175 TBM subjects enrolled in the study. We identified five polymorphisms within TLR2 at positions T597C, T1350C, C1560T, C1716A and T2121C (these numbers are based on the translational start position). The polymorphism frequencies are shown in Table 1 , together with frequencies reported in the National Center for Biotechnology Information database. Two of these SNPs have been previously reported (T597C, T1350C). Three new polymorphisms were found with low frequencies (p0.020) whereas T597C and T1350C were present at higher frequencies (0.36 and 0.25 respectively). We did not detect the mutation Arg753Gln (G2258A) that has been previously reported to be associated with pulmonary TB.
22
TLR2 SNP T597C is associated with susceptibility to TBM We used a case-control study design to determine whether polymorphisms of TLR2 were associated with pulmonary TB and/or TBM. We genotyped the entire sample set of 358 TB cases (175 with TBM, 183 with pulmonary TB) and 392 cord blood controls. Three SNPs (T597C, T1350C and T2121C) were genotyped with allele-specific primer extension assays with detection by Sequenom's mass spectrometry-based technique. The genotypes of the three SNPs in control individuals all displayed Hardy-Weinberg equilibrium (HWE) (P40.05). The allele frequencies of SNP T597C were different between the TB cases (0.297) and controls (0.252) (odds ratio (OR) 1.26, 95% confidence interval (CI): 1.00-1.58, P ¼ 0.05) ( Table 2 ). The genotype frequencies of this SNP were also significantly different in the TB cases when compared to the controls (P ¼ 0.03) ( Table 2 ). There were no genetic associations between the two other SNPs (T1350C and T2121C) and TB ( Table 2) .
We next examined whether clinical disease phenotype -pulmonary or meningeal disease -influenced the association with SNP T597C. We compared the allelic and genotypic frequencies of SNP T597C in these two groups to the control group frequencies. In this sample set, there was no association between SNP T597C and pulmonary TB: the allele frequency of 597C in the pulmonary TB group (0.265) was similar to that in the control group (0.252). However, the SNP was associated with TBM in both allelic and genotypic comparisons ( Table 2) . SNP T597C had a significantly higher allele frequency in TBM patients (0.330) compared to the controls (0.252) (OR795% CI: 1.4771.11À1.94, P ¼ 0.007) ( Table 2 ).
TLR2 SNP 597CC genotype is associated with severity of TBM at the start of treatment We used the likelihood ratio (LR) test to determine whether there is significant evidence of a dominance effect at a particular locus. If the 2df test is a better fit, then there is evidence of a dominance effect rather than a general multiplicative model (which is assumed in the 1df test). The likelihood ratio test showed that there was significant evidence of a genotypic effect (2df) at SNP T597C rather than an allelic effect (1df) (LR w 2 ¼ 6.01, P ¼ 0.014). Therefore, we performed a comparison of genotypic models where allele T was dominant (597TT and 597TC vs 597CC) and where allele T was recessive (597TT vs 597TC and 597CC) to analyse the genotypic effect. We analysed the two models by logistic regression. The choice of model is based on likelihood values and Bayesian information criterion (BIC) values. The model with the smallest BIC is considered as the best fit. The results suggested that the dominant model was better than the recessive model (BIC of dominant model ¼ 680.509oBIC of recessive model ¼ 691.659). We therefore examined SNP597 further by using a dominant model to determine whether there was an increased association with homozygote (597CC) individuals. TLR2 genotype 597CC was associated with susceptibility to both forms of TB (all TB cases vs control, OR795% CI: 2.227 1.23À3.99, P ¼ 0.007) ( Table 3 ). When the analysis was Table 3) . These data support a strong association between 597CC and the development of TBM. When we added dominant SNP T597C data for pulmonary TB, TBM grade I, grade II and grade III into a multiple logistic regression model using control data as a reference, we found that the association with 597CC increased depending on the severity of neurological symptoms (P trend ¼ 0.0001; Table 3 ). In addition, we compared the frequencies of SNP 597CC in TBM with pulmonary TB controls. This adds further stringency to the analysis because pulmonary TB patients were matched to TBM patients by age, sex, ethnicity and location of residence, whereas cord blood controls were only matched by ethnicity. In this comparison, as in the comparison with cord blood controls, 597CC genotype was found to be significantly associated with the severity of TBM. The results of a dominant genotypic comparison for pulmonary TB and TBM were 2.4971.18À5.26 (OR795% CI), P ¼ 0.014 for all TBM; 1.4870.39À5.61, P ¼ 0.563 for TBM grade I; 2.5571.00À6.47, P ¼ 0.047 for TBM grade II; and 4.367 1.46À13.02, P ¼ 0.005 for TBM grade III. Together, these results show that TLR2 SNP T597C is associated with TBM, and the association strengthens proportionately to disease severity.
TLR2 SNP 597CC genotype is strongly associated with TBM patients with evidence of miliary TB We also investigated whether the 597CC genotype was associated with an additional clinical phenotype: TBM with evidence of miliary disease on chest radiography. The diagnosis of miliary TB depends on the appearance of diffuse nodules on chest radiography, which represent individual granulomas formed following haematogenous seeding of the lung. Other organs are often involved and patients with miliary disease are at high risk of extra-pulmonary disease, TBM in particular. Abbreviations: CI, confidence interval; TB, tuberculosis; TBM, tuberculous meningitis; TLR2, Toll-like receptor 2. Note: For odds ratio (OR) calculation, each group was compared with the control group. P trend value was calculated for TB pulmonary and TB meningitis grade I, grade II and grade III into a multiple logistic regression model using control data as a reference. TB all represents the combination of pulmonary and TB meningitis.
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Patients with TBM were divided into those with (43/149) or without (106/149) miliary TB (a chest X-ray was not performed in 26 patients). SNP T597C was strongly associated with TBM with miliary TB in allelic, genotypic and dominant genotypic comparison (Table 4) . Moreover, miliary disease was clearly associated with the 597CC genotype in the dominant genotype comparison (controls vs pulmonary TB OR795% CI: 1.3170.06À2.83, P ¼ 0.497; controls vs TBM without miliary TB OR795% CI: 2.3171.06À5.06, P ¼ 0.032; and controls vs TBM with miliary TB OR795% CI: 5.2872.20À12.65, Po0.0001; Table 4 ). When we analysed dominant data for the various clinical phenotypes in a multiple logistic regression model using control data as a reference, there was a significant association between 597CC genotype and TBM with miliary disease (P trendo0.00001; Table 4 ).
Co-inheritance of TLR2 SNP T597C and TIRAP SNP C558T increases susceptibility to TBM TLR2 interacts with the adaptor protein TIRAP to initiate signalling pathways leading to activation of the innate immune system. We previously found TIRAP SNP C558T to be associated with increased susceptibility to TBM in this same Vietnamese cohort. 25 Therefore, we next analysed the co-inheritance of TLR2 SNP T597C and TIRAP SNP C558T to examine how these two SNPs affect the risk of the development of TBM. When the polymorphism occurred in TIRAP only (TLR2 597T_TIR-AP 558T), the risk for TBM was 3.2 (OR795% CI: 3.271.77À5.75, Po0.0001). If individuals have both SNPs (TLR2 597C, TIRAP 558T), they have a higher risk of TBM (OR795% CI: 5.471.34À21.77, P ¼ 0.008), but the number of subjects available for this analysis were small.
Discussion
In this study, we report the genetic association of a TLR2 SNP with susceptibility to TBM that is enhanced in those with more severe disease as well as those with miliary TB. The molecular mechanism by which this synonymous polymorphism might affect susceptibility to severe TBM is not known. As we have identified all common SNPs (frequency42%) within the coding region of TLR2 in TBM patients, the true causal polymorphism presumably lies nearby, either in the promoter region or in a nearby gene. A microsatellite region within intron 2 of TLR2 shows significant frequency variation across populations and may also influence gene function. Yim et al. 24, 28 found an association between this microsatellite and pulmonary TB among Koreans. It may be that the C allele of SNP T597C has a high level of linkage disequilibrium with the allele of the GT microsatellite that affects gene regulation. The TLR2 SNP T597C has been previously reported with allele 597T being present in 3/110 healthy Caucasian people. 29 However, in the Vietnamese and Japanese populations, 597T is the major allele at a frequency of 0.75 (564/754) and 0.50 (24/48) respectively in the population control group. 30 Therefore, the 597T allele may represent a minor allele in Caucasian populations and a common allele in Asian populations. This may cause differences between disease associations of this SNP in different populations. Work is in progress to investigate the association between the GT microsatellite genotype, SNP T597C and TLR2 gene expression to understand more about gene regulation in individuals with 597CC genotype.
The results of this study suggest that TLR2 may influence more than one step in the pathogenesis of TBM. After bacilli invade the host lung within the pulmonary alveolar macrophage, they replicate and disseminate to the regional lymph nodes. During this early stage of infection -before the development of adaptive immunity -the bacteria can spread haematogenously to other organs in the body and cause extra-pulmonary disease, such as TBM. 31, 32 This step may be determined by the nature and extent of the innate immune response and may be influenced by interaction with TLR2 and M. tuberculosis. We found that SNP T597C was strongly associated with the development of TBM. To further investigate the possibility that this polymorphism influences haematogenous dissemination, we examined whether the SNP was associated with TBM and miliary TB. Miliary TB is a radiographic diagnosis based on the appearance of numerous granuloma throughout the lungs; other organs (for example, brain, kidney, liver, spleen) are often similarly affected. The disease represents the most extensive manifestation of haematogenously disseminated TB, but the underlying mechanism of bacterial dissemination is the same for all forms of extra-pulmonary TB. We found that TLR2 SNP T597C was strongly associated with having both TBM and miliary TB, which provides further support that this SNP influences the haematogenous dissemination of Abbreviations: CI, confidence interval; TB, tuberculosis; TBM, tuberculous meningitis; TLR2, Toll-like receptor 2. Note: For odds ratio (OR) calculation, each group was compared with the control group. P trend value was calculated for TB pulmonary, TBM alone and TBM+miliary TB into a multiple logistic regression model using control data as a reference.
TLR2 and TB meningitis NTT Thuong et al M. tuberculosis. Therefore, T597C may result in an attenuated early innate immune response to infection with M. tuberculosis, a heavier and more prolonged bacillaemia, and a greater chance of developing miliary TB and/or TBM. We also found a strong relationship between TLR2 SNP T597C and the severity of TBM at presentation. This is less readily explained by an increased susceptibility to haematogenous dissemination. In TBM, bacilli seed the meninges or brain parenchyma, forming small subpial or subependymal foci; 33 disease develops some time later when the foci rupture and release bacteria into the subarachnoid space. The bacteria provoke an inflammatory response and symptoms develop. Although the relationship between the inflammatory response and TBM pathogenesis is only partially understood, excessive immune activation is thought to be intimately associated with disease severity and outcome. A number of studies suggest that the intra-cerebral concentrations of cytokines are likely to affect TBM development and severity and that tumour necrosis factor-a secretion is required for successful control of mycobacterial infection.
34À36
Previous immunologic studies in our cohort of TBM patients found that cerebrospinal fluid (CSF) interleukin-6 concentrations were associated with the most severe disease. 37, 38 Given the central role of TLR2 in mediating immune responses, it is possible that TLR2 genetic variants differentially regulate inflammatory pathways and influence the intra-cerebral inflammatory responses that determine severity and outcome of the disease.
In summary, we have found an SNP in the TLR2 gene that was associated with the development of TBM in Vietnamese adults. The relevance of the polymorphism to the pathogenesis of disseminated TB and TBM was further accentuated by the increased strength of the association with TBM and concomitant miliary disease and disease severity at presentation. These findings suggest that innate immune response -triggered through TLR2 -is important in the control of extrapulmonary dissemination of M. tuberculosis and the development of TBM.
Materials and methods
Human subjects and study design Blood samples were collected from 358 HIV-negative adult patients with TB, as previously described. Blood samples from 183 patients with pulmonary TB were collected between April 2003 and December 2004 through the network of district TB control units that exist to implement the directly observed therapy programme in Vietnam. All patients had 'uncomplicated' pulmonary TB, defined as no previous TB treatment, no clinical or radiographic evidence of miliary or extrapulmonary TB and acid fast bacilli in sputum and/or the culture of M. tuberculosis from sputum. As far as possible, pulmonary TB patients were prospectively matched to TBM patients by age (75 years) and district of residence. Gender matching was attempted but not achieved because of a larger number of men with pulmonary TB attending the district control units.
The 
Molecular techniques
Blood was collected in ethylenediaminetetraacetic acid anticoagulant, the plasma was removed and the blood cell pellet was stored at À201C. Genomic DNA was extracted from the blood cell pellet by using either the blood midi kit or maxi kit from Qiagen (Lewes, UK). DNA concentration was measured by picogreen (Molecular Probes Invitrogen, Paisley, UK) using a Tecan fluorescent plate reader.
Nucleotide sequencing
We performed mutation detection on the complete coding region of TLR2 and on part of intron 2, where two microsatellites are located. Together these constitute a region approximately 3 kb in length, which was amplified in two fragments by polymerase chain reaction. These two fragments, 1.34 kb amplified with primers TH31 (5 0 -GTCCCAAAGCATGCTACTCCTGG-3 0 ) and TH28 (5 0 -CATAACCTGAAACAAACTTTCATCGG-3 0 ), and 1.76 kb amplified with primers TH20 (5 0 -TCCATTTT TCAGAACTATCCACTGG-3 0 ) and TH24 (5 0 -TCCTCAA ATGACGGTACATCCACG-3 0 ) in length, were used as templates for polymorphism detection by sequencing. Fourteen sequencing primers were designed to cover this complete region in both forward and reverse directions. DNA sequencing was performed by capillary electrophoresis using a CEQ8000 (Beckman Coulter, Singapore). The sequencing results generated from the 14 individual sequencing primers were assembled and compared to the reference sequence using the Vector NTI contig express program (Vector NTI suite version 7.0). Polymorphisms were verified in both strands of the DNA.
SNP genotyping
Genotyping was carried out by a MassARRAY technique (Sequenom, San Diego, CA, USA) using a chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometer as previously described. 25 All of the TLR2 SNPs were in HWE (P40.05) in population controls.
Statistics
Univariate analysis was performed for categorical variables with a w 2 test; Fisher's exact test was used when the number of samples in a group was less than five. Twosided testing was used to evaluate statistical significance. The choice of predictors associating with TBM was based on the model log-likelihood. The likelihood ratio test was applied to compare two nested models (that is, allelic and genotypic models). The model with higher loglikelihood value was a more compatible model. 39 For non-nested models such as dominant and recessive models, the model choice was based on the BIC value. 40 The model with the smaller BIC was predicted to be the better model. Associations between different SNPs, disease phenotype and disease severity were modeled by multiple logistic regression using control data as a reference (P trend). All analyses were performed using STATA (version 8.0, TX, USA) and SPSS (version 14.0, Chicago, IL, USA).
